BRIEF-Ipsen and Exelixis announce Phase 2 results of CABOSUN trial

* ANNOUNCED ON SUNDAY, RESULTS FROM PHASE 2 CABOSUN TRIAL OFCABOZANTINIB VERSUS SUNITINIB IN PREVIOUSLY UNTREATED ADVANCEDRENAL CELL CARCINOMA
The post BRIEF-Ipsen and Exelixis announce Phase 2 results of CABOSUN trial appeared first on RocketNews | Top News Stories From Around the Globe.